Chemotherapy
499 articles
My Two-Year Journey with Pancreatic Cancer
When filmmaker Glen Trotiner was diagnosed with pancreatic cancer, he learned a new meaning for “treatment.”
Family, Friends, Hope, Strength, and Prayer
Susan Wells had chemotherapy but her treatment took a detour into more chemo and a clinical trial before she had a Whipple procedure.
Putting the Immune System on the Offensive
A discussion of immunology in cancer treatment, focusing on the work of Elizabeth Jaffe, M.D., and her cancer vaccine and checkpoint inhibitors.
Personalizing Pancreatic Cancer Treatment
Dr. Mark Ricigliano takes a closer look at the genetics of circulating tumor cells, to personalize pancreatic cancer treatment for the best results.
Novel Drug Therapy Kills Pancreatic Cancer Cells by Reducing Levels of Antioxidants
New research finds that reducing antioxidants can help kill pancreatic cancer cells, suggesting a new direction for treatment.
The First Line of Defense against Pancreatic Cancer
Drs. Allyson Ocean and David Tuveson explain why pancreatic cancer patients should participate in clinical trials at the time of diagnosis.
Two Enzymes May Predict Pancreatic Cancer Severity and Development
Dr. Alexandra Newton and her lab have found that the relationship between two enzymes common to cancer may play a role in pancreatic cancer prognosis.
Pancreatic Cancer Science—2021 in Review
As the year winds down Let’s Win provides an overall look at the highlights of 2021 in pancreatic cancer science.
New Study Aims to Reduce Recurrence Risk for Select Patients
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.
A Report from ASCO GI 2022
Clinical trials were reported on at ASCO GI 2022, as well as reports on COVID, virtual tumor boards, and racial disparities in treatment.
Surprising Clinical Trial Results in Pancreatic and Rectal Cancer
Let’s Win Scientific Advisory Board Chair Dr. Allyson Ocean explains the surprising clinical trial results in pancreatic and rectal cancers.
A Year in Review: 2022 in Research
What progress was made in pancreatic treatment and screening? Learn about the major pancreatic cancer developments of 2022.
No One Fights Alone
Because of her grandfather, Rhonda Havig knew she had a family history of pancreatic cancer. But her own diagnosis was still a surprise.
Using Ice to Prevent Neuropathy
Neuropathy–tingling or numbness in your extremities–is a common side effect of chemotherapy. Learn more about the role of ice in preventing neuropathy.
New Vaccine Harnesses Power Of the Lymph Nodes
A promising new vaccine targets KRAS, the most common mutation in pancreatic cancer. Dr. Shubham Pant provides an update.